Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-24 · accession 0001048477-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-24 | BMRN | Burkhart Erin | CAO, GVP | S - Sale | $68.38 | -1,344 | 13.1K | -9% | -$91.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | S | D | 1,344 | $68.38 | 13,105 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on November 26, 2024. |